Purchases and Sales Made in Q3 2023 in Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT) during Q3 2023. The information is specifically focused on institutions that hold shares of Nuvectis Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
45K+ 14.29% |
$579K - $732K
|
359K
$1.8M
|
|
|
Oct 10, 2023
Q3 2023
|
Baldwin Brothers LLC
|
BUY
|
- |
26.3K+ 29.22% |
$339K - $429K
|
116K
$584K
|
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
25.2K+ 9.47% |
$325K - $410K
|
291K
$1.46M
|
|
|
Nov 13, 2023
Q3 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
17.1K+ 15.22% |
$221K - $279K
|
130K
$651K
|
|
|
Nov 13, 2023
Q3 2023
|
Moran Wealth Management, LLC
Naples, FL |
BUY
|
- |
16.7KNew |
$215K - $272K
|
16.7K
$83.8K
|
|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
6.74K+ 1241.07% |
$86.9K - $110K
|
7.28K
$36.6K
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
BUY
|
- |
2.88K+ 2.74% |
$37.1K - $46.9K
|
108K
$543K
|
|
|
Oct 26, 2023
Q3 2023
|
Strs Ohio
|
BUY
|
- |
2.5K+ 178.57% |
$32.2K - $40.7K
|
3.9K
$19.6K
|
|
|
Nov 08, 2023
Q3 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
1.93K+ 10.7% |
$24.8K - $31.4K
|
19.9K
$100K
|
|
|
Nov 13, 2023
Q3 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
1.05K+ 1.96% |
$13.6K - $17.2K
|
54.7K
$275K
|
|
|
Nov 09, 2023
Q3 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
495+ 7.3% |
$6.38K - $8.06K
|
7.27K
$36.5K
|
|
|
Nov 13, 2023
Q3 2023
|
American International Group, Inc.
New York, NY |
BUY
|
- |
413+ 12.52% |
$5.32K - $6.73K
|
3.71K
$18.6K
|
|
|
Nov 07, 2023
Q3 2023
|
New York State Common Retirement Fund
|
BUY
|
- |
72+ 1.26% |
$928 - $1.17K
|
5.77K
$29K
|
|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
BUY
|
- |
18+ 1.31% |
$232 - $293
|
1.39K
$6.97K
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 07, 2023
Q3 2023
|
Dorsey Wright & Associates
|
SELL
|
- |
-48- 3.32% |
$619 - $782
|
1.4K
$7.01K
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-203- 5.1% |
$2.62K - $3.31K
|
3.78K
$19K
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-558- 10.22% |
$7.19K - $9.09K
|
4.9K
$24.6K
|
|
|
Nov 14, 2023
Q3 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-638- 27.99% |
$8.22K - $10.4K
|
1.64K
$8.24K
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1.38K- 48.51% |
$17.8K - $22.5K
|
1.47K
$7.35K
|
|
|
Nov 14, 2023
Q3 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-1.6K- 59.58% |
$20.7K - $26.1K
|
1.09K
$5.46K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.62K- 31.82% |
$20.9K - $26.5K
|
3.48K
$17.5K
|
|
|
Nov 09, 2023
Q3 2023
|
Citigroup Inc
|
SELL
|
- |
-2.03K- 99.75% |
$26.2K - $33.1K
|
5
$25.1
|
|
|
Nov 13, 2023
Q3 2023
|
Hollencrest Capital Management
|
SELL
|
- |
-2.76K- 90.79% |
$35.6K - $45K
|
280
$1.41K
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-5.69K- 13.62% |
$73.3K - $92.7K
|
36.1K
$181K
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-11K- 30.22% |
$142K - $179K
|
25.4K
$128K
|
|
|
Nov 02, 2023
Q3 2023
|
Forbes J M & CO LLP
|
SELL
|
- |
-33K- 49.25% |
$425K - $538K
|
34K
$171K
|